Nicole M. Sodir, Ph.D.
Affiliations: | 2006 | University of Southern California, Los Angeles, CA, United States |
Area:
Molecular Biology, Genetics, OncologyGoogle:
"Nicole Sodir"Parents
Sign in to add mentor| Peter W. Laird | grad student | 2006 | USC | |
| (Tumorigenesis in mouse models of intestinal cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sodir NM, Pathria G, Adamkewicz JI, et al. (2023) SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment. Cancer Discovery. OF1-OF17 |
| Antal CE, Oh TG, Aigner S, et al. (2023) A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer. Nature Communications. 14: 5195 |
| Sodir NM, Pellegrinet L, Kortlever RM, et al. (2022) Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution. Nature Communications. 13: 6782 |
| Sodir NM, Kortlever RM, Barthet VJA, et al. (2020) Myc instructs and maintains pancreatic adenocarcinoma phenotype. Cancer Discovery |
| Sodir NM, Kortlever RM, Barthet VJA, et al. (2019) Abstract LB-034: Myc instructs and maintains pancreatic adenocarcinoma phenotype Cancer Research. 79 |
| Kortlever RM, Sodir NM, Wilson CH, et al. (2017) Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 171: 1301-1315.e14 |
| Evan GI, Hah N, Littlewood TD, et al. (2017) Re-engineering the Pancreas Tumor Microenvironment: A "Regenerative Program" Hacked. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 1647-1655 |
| Kortlever RM, Sodir NM, Wilson CH, et al. (2016) Abstract 535: Deregulated Myc is an immunosuppressive switch Cancer Research. 76: 535-535 |
| Escobar D, Hepp MI, Farkas C, et al. (2015) Sall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicin. Cell Death & Disease. 6: e1816 |
| Massó-Vallés D, Jauset T, Serrano E, et al. (2015) Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma. Cancer Research. 75: 1675-81 |